{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:43Z","timestamp":1787068483554,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1113A"],"award-info":[{"award-number":["01GM1113A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leber hereditary optic neuropathy (LHON) is the most common mitochondrial disorder, frequently resulting in acute or subacute severe bilateral central vision loss. Vitamin B12 deficiency is also a known cause of optic neuropathy through mitochondrial dysfunction. Here we evaluated the prevalence and clinical significance of vitamin B12 deficiency in a large cohort of LHON patients and asymptomatic mutation carriers from a tertiary referral center.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From the Munich LHON prospective cohort study, participants included all LHON patients and asymptomatic LHON mutation carriers, who were recruited between February 2014 and March 2020 and consented to participate. Neurological, general, and ophthalmological examinations were regularly performed, as were laboratory tests. Vitamin B12 deficiency was diagnosed if serum vitamin\u00a0B12 was below 201\u00a0pg\/mL, or if 201\u2013339\u00a0pg\/mL plus low serum holotranscobalamin or elevated serum methylmalonic acid or elevated total plasma homocysteine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We analyzed 244 subjects, including 147 symptomatic LHON patients (74% males) and 97 asymptomatic mutation carriers (31% males). Median age at study baseline was 34\u00a0years (range 5\u201382\u00a0years). The prevalence of vitamin B12 deficiency was higher for LHON mutation carriers than for the general population in all age categories. This was statistically significant for the LHON mutation carriers under 65\u00a0years (21% vs. 5\u20137%, <jats:italic>p<\/jats:italic>\u2009=\u20090.002). While vitamin B12 deficiency prevalence was not statistically different between LHON patients and asymptomatic mutation carriers, its clinical correlates, e.g., macrocytosis and polyneuropathy, were more frequent in the subgroup of LHON patients. Excessive alcohol consumption was a significant predictor of vitamin B12 deficiency (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The high prevalence of vitamin\u00a0B12 deficiency in LHON mutation carriers, both asymptomatic mutation carriers and LHON patients, highlights the need for regular vitamin\u00a0B12 screening in this population, in order to ensure early treatment, aiming for better outcomes. Our study is not conclusive regarding vitamin B12 deficiency as determinant for disease conversion in LHON, and further research is warranted to disentangle the role of vitamin B12 in the pathophysiology and prognosis of LHON.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02453-z","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:03:34Z","timestamp":1660043014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vitamin B12 in Leber hereditary optic neuropathy mutation carriers: a prospective cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Julia","family":"Zibold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"von Livonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Kolarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia S.","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-7570","authenticated-orcid":false,"given":"Claudia B.","family":"Catarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"2","key":"2453_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"PY Man","year":"2003","unstructured":"Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2):333\u20139.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2453_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81\u2013114.","journal-title":"Prog Retin Eye Res"},{"issue":"Pt 9","key":"2453_CR3","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain J Neurol. 2009;132(Pt 9):2317\u201326.","journal-title":"Brain J Neurol"},{"issue":"11","key":"2453_CR4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1055\/a-0972-1552","volume":"236","author":"C Priglinger","year":"2019","unstructured":"Priglinger C, Klopstock T, Rudolph G, Priglinger SG. Leber\u2019s hereditary optic neuropathy. Klin Monbl Augenheilkd. 2019;236(11):1271\u201382.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"12","key":"2453_CR5","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1167\/iovs.06-0520","volume":"47","author":"P Barboni","year":"2006","unstructured":"Barboni P, Savini G, Valentino ML, La Morgia C, Bellusci C, De Negri AM, et al. Leber\u2019s hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci. 2006;47(12):5303\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2453_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-014-0158-9","volume":"9","author":"K Dimitriadis","year":"2014","unstructured":"Dimitriadis K, Leonhardt M, Yu-Wai-Man P, Kirkman MA, Korsten A, De Coo IF, et al. Leber\u2019s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients. Orphanet J Rare Dis. 2014;9(1):1\u20135.","journal-title":"Orphanet J Rare Dis"},{"issue":"4884","key":"2453_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, et al. Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy. Science. 1988;242(4884):1427\u201330.","journal-title":"Science"},{"issue":"5","key":"2453_CR8","first-page":"939","volume":"49","author":"N Howell","year":"1991","unstructured":"Howell N, Bindoff LA, McCullough DA, Kubacka I, Poulton J, Mackey D, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet. 1991;49(5):939\u201350.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2453_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/0006-291X(92)90479-5","volume":"187","author":"DR Johns","year":"1992","unstructured":"Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun. 1992;187(3):1551\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2453_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/jmg.39.3.162","volume":"39","author":"P Yu-Wai-Man","year":"2002","unstructured":"Yu-Wai-Man P, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39(3):162\u20139.","journal-title":"J Med Genet"},{"issue":"5","key":"2453_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11910-020-01032-8","volume":"20","author":"AJ Mejia-Vergara","year":"2020","unstructured":"Mejia-Vergara AJ, Seleme N, Sadun AA, Karanjia R. Pathophysiology of conversion to symptomatic leber hereditary optic neuropathy and therapeutic implications: a review. Curr Neurol Neurosci Rep. 2020;20(5):11.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2453_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mito.2018.07.007","volume":"46","author":"K Kogachi","year":"2019","unstructured":"Kogachi K, Ter-Zakarian A, Asanad S, Sadun A, Karanjia R. Toxic medications in Leber\u2019s hereditary optic neuropathy. Mitochondrion. 2019;46:270\u20137.","journal-title":"Mitochondrion"},{"issue":"1","key":"2453_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13023-021-01690-y","volume":"16","author":"M-C Reinert","year":"2021","unstructured":"Reinert M-C, Pacheu-Grau D, Catarino CB, Klopstock T, Ohlenbusch A, Schittkowski M, et al. Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy. Orphanet J Rare Dis. 2021;16(1):64.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"2453_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00417-006-0269-7","volume":"244","author":"JW Pott","year":"2006","unstructured":"Pott JW, Wong KH. Leber\u2019s hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1357\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2453_CR15","unstructured":"Miller D GC, Macri C. Case report: Leber hereditary optic neuropathy in a 60-year-old man with vitamin B12 deficiency. Pract Neurol. 2010;2020:25\u201327."},{"issue":"1\u20132","key":"2453_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cbi.2006.05.010","volume":"163","author":"F Depeint","year":"2006","unstructured":"Depeint F, Bruce WR, Shangari N, Mehta R, O\u2019Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006;163(1\u20132):113\u201332.","journal-title":"Chem Biol Interact"},{"issue":"suppl_4","key":"2453_CR17","doi-asserted-by":"publisher","first-page":"1995s","DOI":"10.1093\/jn\/nxy201","volume":"148","author":"LH Allen","year":"2018","unstructured":"Allen LH, Miller JW, de Groot L, Rosenberg IH, Smith AD, Refsum H, et al. Biomarkers of nutrition for development (BOND): vitamin B-12 review. J Nutr. 2018;148(suppl_4):1995s-2027s-.","journal-title":"J Nutr"},{"key":"2453_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmolb.2016.00027","volume":"3","author":"L Hannibal","year":"2016","unstructured":"Hannibal L, Lysne V, Bj\u00f8rke-Monsen AL, Behringer S, Gr\u00fcnert SC, Spiekerkoetter U, et al. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency. Front Mol Biosci. 2016;3:27.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2453_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1389200052997384","volume":"6","author":"W Herrmann","year":"2005","unstructured":"Herrmann W, Obeid R, Schorr H, Geisel J. The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings. Curr Drug Metab. 2005;6(1):47\u201353.","journal-title":"Curr Drug Metab"},{"issue":"7","key":"2453_CR20","doi-asserted-by":"publisher","first-page":"1636s","DOI":"10.3945\/jn.114.206599","volume":"145","author":"LB Bailey","year":"2015","unstructured":"Bailey LB, Stover PJ, McNulty H, Fenech MF, Gregory JF 3rd, Mills JL, et al. Biomarkers of nutrition for development-folate review. J Nutr. 2015;145(7):1636s-s1680.","journal-title":"J Nutr"},{"issue":"2","key":"2453_CR21","doi-asserted-by":"publisher","first-page":"693s","DOI":"10.3945\/ajcn.2008.26947A","volume":"89","author":"LH Allen","year":"2009","unstructured":"Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89(2):693s-s696.","journal-title":"Am J Clin Nutr"},{"issue":"40","key":"2453_CR22","first-page":"680","volume":"105","author":"W Herrmann","year":"2008","unstructured":"Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int. 2008;105(40):680\u20135.","journal-title":"Dtsch Arztebl Int"},{"issue":"21","key":"2453_CR23","first-page":"2041","volume":"368","author":"SP Stabler","year":"2013","unstructured":"Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(21):2041\u20132.","journal-title":"N Engl J Med"},{"key":"2453_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cca.2013.04.002","volume":"422","author":"SN Fedosov","year":"2013","unstructured":"Fedosov SN. Biochemical markers of vitamin B12 deficiency combined in one diagnostic parameter: the age-dependence and association with cognitive function and blood hemoglobin. Clin Chim Acta. 2013;422:47\u201353.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2453_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/nu8120767","volume":"8","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Lagan\u00e0 AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, et al. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients. 2016;8(12):767.","journal-title":"Nutrients"},{"issue":"4","key":"2453_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjh.12959","volume":"166","author":"V Devalia","year":"2014","unstructured":"Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496\u2013513.","journal-title":"Br J Haematol"},{"issue":"12","key":"2453_CR27","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.3390\/nu5125031","volume":"5","author":"U Gr\u00f6ber","year":"2013","unstructured":"Gr\u00f6ber U, Kisters K, Schmidt J. Neuroenhancement with vitamin B12-underestimated neurological significance. Nutrients. 2013;5(12):5031\u201345.","journal-title":"Nutrients"},{"key":"2453_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-94-007-2199-9_16","volume":"56","author":"W Herrmann","year":"2012","unstructured":"Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012;56:301\u201322.","journal-title":"Subcell Biochem"},{"issue":"1","key":"2453_CR29","doi-asserted-by":"publisher","first-page":"348s","DOI":"10.3945\/ajcn.111.013441","volume":"94","author":"R Carmel","year":"2011","unstructured":"Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94(1):348s-s358.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"2453_CR30","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1515\/CCLM.2003.227","volume":"41","author":"W Herrmann","year":"2003","unstructured":"Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med. 2003;41(11):1478\u201388.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2453_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2796.2011.02485.x","volume":"271","author":"AD Smith","year":"2012","unstructured":"Smith AD, Refsum H. Do we need to reconsider the desirable blood level of vitamin B12? J Intern Med. 2012;271(2):179\u201382.","journal-title":"J Intern Med"},{"issue":"2","key":"2453_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7861\/clinmedicine.15-2-145","volume":"15","author":"MJ Shipton","year":"2015","unstructured":"Shipton MJ, Thachil J. Vitamin B12 deficiency\u2014a 21st century perspective. Clin Med (Lond). 2015;15(2):145\u201350.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"2453_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.neuropsych.11020052","volume":"24","author":"C Lachner","year":"2012","unstructured":"Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012;24(1):5\u201315.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"13","key":"2453_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274(13):1049\u201357.","journal-title":"JAMA"},{"issue":"7","key":"2453_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D\u2019Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med. 2002;346(7):476\u201383.","journal-title":"N Engl J Med"},{"issue":"1","key":"2453_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1076\/soph.17.1.29.10290","volume":"17","author":"AA Sadun","year":"2002","unstructured":"Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol. 2002;17(1):29\u201332.","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"2453_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005792-199107000-00001","volume":"70","author":"EB Healton","year":"1991","unstructured":"Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70(4):229\u201345.","journal-title":"Medicine (Baltimore)"},{"key":"2453_CR38","first-page":"Cd004655","volume":"3","author":"J Vidal-Alaball","year":"2005","unstructured":"Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005;3:Cd004655.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt 9","key":"2453_CR39","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain J Neurol. 2011;134(Pt 9):2677\u201386.","journal-title":"Brain J Neurol"},{"issue":"4","key":"2453_CR40","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/WNO.0000000000001023","volume":"40","author":"CB Catarino","year":"2020","unstructured":"Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, et al. Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy. J Neuroophthalmol. 2020;40(4):558\u201365.","journal-title":"J Neuroophthalmol"},{"key":"2453_CR41","unstructured":"Guideline A. S3-Leitlinie \u201cAlkoholbezogene St\u00f6rungen: Screening, Diagnose und Behandlung\u201d. AWMF-Register Nr 076\u2013001. 2016."},{"issue":"3","key":"2453_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12603-010-0280-x","volume":"15","author":"W Chatthanawaree","year":"2011","unstructured":"Chatthanawaree W. Biomarkers of cobalamin (vitamin B12) deficiency and its application. J Nutr Health Aging. 2011;15(3):227\u201331.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"2453_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","volume":"37","author":"V Carelli","year":"2017","unstructured":"Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagr\u00e8ze WA, et al. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuro-Ophthalmol. 2017;37(4):371\u201381.","journal-title":"J Neuro-Ophthalmol"},{"issue":"1","key":"2453_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-021-01724-5","volume":"16","author":"A Rabenstein","year":"2021","unstructured":"Rabenstein A, Catarino CB, Rampeltshammer V, Schindler D, Gallenm\u00fcller C, Priglinger C, et al. Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber\u2019s hereditary optic neuropathy mutation carriers: a prospective cohort study. Orphanet J Rare Dis. 2021;16(1):127.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2453_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1024\/0939-5911.a000275","volume":"59","author":"A Pabst","year":"2013","unstructured":"Pabst A, Kraus L, Matos EG, Piontek D. Substanzkonsum und substanzbezogene St\u00f6rungen in Deutschland im Jahr 2012. SUCHT. 2013;59(6):321\u201331.","journal-title":"SUCHT"},{"issue":"6","key":"2453_CR46","first-page":"83","volume":"115","author":"C Sommer","year":"2018","unstructured":"Sommer C, Geber C, Young P, Forst R, Birklein F, Schoser B. Polyneuropathies. Dtsch Arztebl Int. 2018;115(6):83\u201390.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"2453_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/alcalc\/agw031","volume":"51","author":"C Fern\u00e1ndez-Rodr\u00edguez","year":"2016","unstructured":"Fern\u00e1ndez-Rodr\u00edguez C, Gonz\u00e1lez-Reimers E, Quintero-Platt G, de la Vega-Prieto MJ, P\u00e9rez-Hern\u00e1ndez O, Mart\u00edn-Gonz\u00e1lez C, et al. Homocysteine, liver function derangement and brain atrophy in alcoholics. Alcohol Alcohol. 2016;51(6):691\u20137.","journal-title":"Alcohol Alcohol"},{"issue":"9","key":"2453_CR48","doi-asserted-by":"publisher","first-page":"e45979","DOI":"10.1371\/journal.pone.0045979","volume":"7","author":"JF Arendt","year":"2012","unstructured":"Arendt JF, Nexo E. Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS ONE. 2012;7(9):e45979.","journal-title":"PLoS ONE"},{"issue":"6","key":"2453_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/qjmed\/hct051","volume":"106","author":"E Andr\u00e8s","year":"2013","unstructured":"Andr\u00e8s E, Serraj K, Zhu J, Vermorken AJ. The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013;106(6):505\u201315.","journal-title":"QJM"},{"issue":"1","key":"2453_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/mus.26783","volume":"62","author":"KG Gwathmey","year":"2020","unstructured":"Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle Nerve. 2020;62(1):13\u201329.","journal-title":"Muscle Nerve"},{"issue":"19","key":"2453_CR51","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/archinte.158.19.2101","volume":"158","author":"JG Ray","year":"1998","unstructured":"Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158(19):2101\u20136.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2453_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-0037-1614438","volume":"81","author":"M Cattaneo","year":"1999","unstructured":"Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81(2):165\u201376.","journal-title":"Thromb Haemost"},{"issue":"1","key":"2453_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53\u201389.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"2453_CR54","first-page":"Cd004426","volume":"2012","author":"G Pfeffer","year":"2012","unstructured":"Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev. 2012;2012(4):Cd004426.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2453_CR55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","volume":"9","author":"G Pfeffer","year":"2013","unstructured":"Pfeffer G, Horvath R, Klopstock T, Mootha VK, Suomalainen A, Koene S, et al. New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol. 2013;9(8):474\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2453_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1182\/blood.V76.5.871.871","volume":"76","author":"SP Stabler","year":"1990","unstructured":"Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76(5):871\u201381.","journal-title":"Blood"},{"key":"2453_CR57","doi-asserted-by":"publisher","first-page":"7468506","DOI":"10.1155\/2020\/7468506","volume":"2020","author":"A Jarquin Campos","year":"2020","unstructured":"Jarquin Campos A, Risch L, Nydegger U, Wiesner J, Vazquez Van Dyck M, Renz H, et al. Diagnostic accuracy of holotranscobalamin, vitamin B12, methylmalonic acid, and homocysteine in detecting B12 deficiency in a large, mixed patient population. Dis Markers. 2020;2020:7468506.","journal-title":"Dis Markers"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02453-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02453-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T05:12:28Z","timestamp":1668661948000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02453-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02453-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the appropriate ethics committee of Ludwig-Maximilians-University (project number 278-13) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants and\/or legal guardians gave written informed consent, or assent if under 18\u00a0years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants and\/or legal guardians gave written informed consent, or assent if under 18\u00a0years of age.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TK has been principal investigator or investigator in industry-sponsored trials funded by Santhera Pharmaceuticals and GenSight Biologics, served on scientific advisory board and received speaker honoraria and travel costs from Santhera Pharmaceuticals, Chiesi GmbH and GenSight Biologics. CBC received travel costs from Santhera Pharmaceuticals and GenSight Biologics. JZ, BvL, HK, GR and CSP declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}